Journals / Turkish Journal of Surgery / 2020 / Cilt: 36 - Sayı: 1

The efficacy of clinical pathway in gastric cancer surgery

Mide kanseri cerrahisinde klinik yolak kullanımının etkinliği

Pages
39–47
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Overall complication rate was lower in theclinical pathway group, while there was no statistically significant difference in major complication rates.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Clinical pathways are useful tools for surgical quality improvement and better peri-operative clinical outcomes for patients undergoingmajor surgery.
📊
Key Findings & Data:The patients were divided into two groupsbased on the date when the clinical pathway was first used: The control group (May 2015-May 2016) and the clinical pathway group (June 2016-December 2017).
💡
Conclusion & Impact:Overall complication rate was lower in theclinical pathway group, while there was no statistically significant difference in major complication rates.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Clinical pathways are useful tools for surgical quality improvement and better peri-operative clinical outcomes for patients undergoingmajor surgery. This study aimed to evaluate the influence of clinical pathway on early postoperative outcomes for gastric cancer patients.Material and Methods: The study was designed as a retrospective cohort observational study. Patients who had undergone curative gastrectomy forgastric cancer were evaluated by using the gastric cancer database, which was prospectively maintained. The patients were divided into two groupsbased on the date when the clinical pathway was first used: The control group (May 2015-May 2016) and the clinical pathway group (June 2016-December 2017). Early postoperative outcomes including the length of hospital stay, start of the day of diet, and 30-day complications including reoperation,and operative mortality were compared after propensity score matching.Results: A total of 101 patients were analyzed, and the data of 70 patients (35 patients in each group) were compared after matching. Clinical pathwaygroup demonstrated shorter hospital stay, earlier nasogastric tube removal, and start of earlier liquid/soft diet. Overall complication rate was lower in theclinical pathway group, while there was no statistically significant difference in major complication rates. No statistically significant difference was observedbetween the groups in terms of reoperation and operative mortality.Conclusion: Clinical pathway may shorten the postoperative length of hospital stay and reduce the overall complication rate without increasing majormorbidity in patients undergoing elective gastric cancer surgery.

Özet

Giriş ve Amaç: Klinik yolaklar cerrahi kalitenin iyileştirilmesinde kullanılan yararlı araçlardır ve majör cerrahi geçiren hastalarda ameliyat sonrası daha iyi klinik sonuç elde edilmesinde yardımcı olur. Bu çalışmada, mide kanseri hastalarında klinik yolak kullanımının erken postoperatif sonuçlar üzerine olan etkisinin değerlendirilmesi amaçlanmıştır. Gereç ve Yöntem: Bu çalışma retrospektif bir kohort çalışma olarak dizayn edildi. Prospektif olarak kayıt yapılan veritabanından, mide kanseri nedeniyle ameliyat edilen hastaların verileri elde edildi. Hastalar klinik yolağın kullanıma girdiği tarihe göre iki gruba ayrıldı: kontrol grup (Mayıs 2015-Mayıs 2016) ve klinik yolak grubu (Haziran 2016-Aralık 2017). Eşleştirilmiş gruplarda hastaların hastanede kalış süresi, oral gıda başlama zamanı ve 30 gün komplikasyon oranları gibi erken dönem klinik sonuçları karşılaştırıldı. Bulgular: Toplam 101 hasta analiz edilmiştir ve eşleştirme sonrası 70 hastanın (her grupta 35 hasta) verileri karşılaştırılmıştır. Klinik yolak grubundaki hastaların daha kısa süre hastanede kaldığı, nazogastrik tüpün daha erken çıkarıldığı ve sıvı/yumuşak gıdaya daha erken dönemde başlandığı tespit edilmiştir. Tüm komplikasyon oranı klinik yolak grubunda daha düşük iken, majör komplikasyon açısından gruplar arasında istatistiksel açıdan fark görülmemiştir. Reoperasyon ve mortalite açısından da istatistiksel olarak anlamlı bir fark saptanmamıştır. Sonuç: Klinik yolak kullanımı mide kanseri nedeniyle elektif ameliyat edilen hastalarda hastanede kalış süresini kısaltabilir ve majör komplikasyonu artırmadan tüm komplikasyon oranlarını azaltabilir.

🔖

Cite This Article

GÜNER, A. (2022). The efficacy of clinical pathway in gastric cancer surgery. Turkish Journal of Surgery, Cilt: 36 - Sayı: 1, 39–47. https://ajindex.com/articles/614306

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Grumbach K, Lucey CR, Johnston SC. Transforming from centers of learning to learning health systems: the challenge for academic health centers. JAMA 2014 19
  2. 311(11):1109-10. [CrossRef] 2. Chakravarty A, Parmar NK, Ranyal RK. Total quality management - the new paradigm in health care management. Med J Armed Forces India 2001
  3. 57(3):226-9. [CrossRef] 3. Lynn PA. Relationship between total quality management, critical paths, and outcomes management. Semin Nurse Manag 1996
  4. 4(3):163-7. [CrossRef] 4. Carman JM, Shortell SM, Foster RW, Hughes EF, Boerstler H, JL OB, et al. Keys for successful implementation of total quality management in hospitals. Health Care Manage Rev 2010
  5. 35(4):283-93. [CrossRef] 5. Sihoe AD. Clinical pathway for video-assisted thoracic surgery: the Hong Kong story. J Thorac Dis 2016
  6. 8(Suppl 1):S12-22. [CrossRef] 6. Tastan S, Hatipoglu S, Iyigun E, Kilic S. Implementation of a clinical pathway in breast cancer patients undergoing breast surgery. Eur J Oncol Nurs 2012
  7. 16(4):368-74. [CrossRef] 7. Campillo-Soto A, Martin-Lorenzo JG, Liron-Ruiz R, Torralba-Martinez JA, Bento-Gerard M, Flores-Pastor B, et al. Evaluation of the clinical pathway for laparoscopic bariatric surgery. Obes Surg 2008
  8. 18(4):395- 400. [CrossRef] 8. Ovaere S, Boscart I, Parmentier I, Steelant PJ, Gabriel T, Allewaert J, et al. The effectiveness of a clinical pathway in liver surgery: a case-control study. J Gastrointest Surg 2018
  9. 22(4):684-94. [CrossRef] 9. Refai M, Salati M, Tiberi M, Sabbatini A, Gentili P. Clinical pathway for thoracic surgery in an Italian centre. J Thorac Dis 2016
  10. 8(Suppl 1):S23- 8. [CrossRef] 10. van der Kolk M, van den Boogaard M, Ter Brugge-Speelman C, Hol J, Noyez L, van Laarhoven K, et al. Development and implementation of a clinical pathway for cardiac surgery in the intensive care unit: effects on protocol adherence. J Eval Clin Pract 2017
  11. 23(6):1289-98. [CrossRef] 11. Uslu A, Zengel B, Ilhan E, Aykas A, Simsek C, Ureyen O, et al. Survival outcomes after D1 and D2 lymphadenectomy with R0 resection in stage II-III gastric cancer: longitudinal follow-up in a single center. Turk J Surg 2018
  12. 34(2):125-30. [CrossRef] 12. Ozmen MM, Ozmen F, Zulfikaroglu B. Lymph nodes in gastric cancer. J Surg Oncol 2008
  13. 98(6):476-81. [CrossRef] 13. Bartlett EK, Roses RE, Kelz RR, Drebin JA, Fraker DL, Karakousis GC. Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Pro